Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity.
key Products/Revenue Segments include Income From Contracts, Sale of services, Other Operating Revenue ... As on 30-09-2024, the company has a total of 4.24 Crore shares outstanding.ABB Power Share ...
Shore Power Market Size Anticipated To Hit USD 3.3 Billion By 2031, Growing At 10.2% CAGR| Transparency Market Research, Inc. ( MENAFN - GlobeNewsWire - Nasdaq) Improvements in shore power ...